Search results
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via Yahoo News· 3 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received...
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via Yahoo Finance· 20 hours agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, ...
FDA grants full approval for Pfizer's cervical cancer drug
New Hampshire Union Leader· 3 days agoThe Food and Drug Administration (FDA) granted full approval for Pfizer'sdrug for treating cervical ...
Southern Nevada oncologists struggling to treat cancer patients during drug shortage
FOX 5 Las Vegas· 2 days agoFor those who get a life-altering diagnosis such as cancer, people seek treatment. This has left...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 7 days agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 20 hours agoRegeneron's anti-inflammatory drug Dupixent brought in sales of $3.08 billion, as recorded by...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 19 hours agoMariana, which specializes in the targeted radiation medicines, could receive up to $750 million...
GV spinout launches with $67M, counterintuitive idea to ‘overactivate’ cancer - Boston Business...
The Business Journals· 20 hours agoDelphia Therapeutics Inc. is the brainchild of its co-founders and oncology drug developers Kevin...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 17 hours agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Bloomberg Law· 9 hours agoprioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing a ...